Efficacy of pharmacological versus psychotherapeutic therapies in adults with attention deficit/hyperactivity disorder (ADHD): An empirical meta-analysis;Zur Wirksamkeit pharmakologischer und psychotherapeutischer Therapien bei Aufmerksamkeitsdefizit-/Hyperaktivitätsstörung (ADHS) im Erwachsenenalter: Eine empirische Metaanalyse

Verhaltenstherapie

Volumn 21, Issue 4, 2011, Pages 229-238

  Linderkamp, Friedrich ^a   Lauth, Gerhard ^b  

^a UNIVERSITY OF OLDENBURG   (Germany)

^b UNIVERSITY OF COLOGNE   (Germany)

Author keywords

ADHD; Adulthood; Meta analysis; Pharmacotherapy; Therapy research

Indexed keywords

PSYCHOTROPIC AGENT;

ARTICLE; ATTENTION DEFICIT DISORDER; COMPARATIVE EFFECTIVENESS; DRUG EFFICACY; HUMAN; META ANALYSIS; PSYCHOTHERAPY; THERAPY EFFECT;

EID: 82955250002     PISSN: 10166262     EISSN: 14230402     Source Type: Journal    
DOI: 10.1159/000332429     Document Type: Article

References (88)

1. Adler L, Liebowitz M, Kronenberger W, Qiao M, Rubin R, et al.: Atomoxetine treatment in adults with attention-deficit/hyperactivity disorder and comorbid social anxiety disorder. Depress Anxiety 2009a;26:212-221.
2. Adler L, Spencer T, Brown T, Holdnack J, Saylor K, et al.: Once-daily atomoxetine for adult attentiondeficit/ hyperactivity disorder: A 6-month doubleblind trial. J Clin Psychopharmacol 2009b;29:44-50.
3. Adler LA, Spencer T, McGough JJ, Jiang H, Muniz R: Long-term effectiveness and safety of dexmethylphenidate extended-release capsules in adult ADHD. J Atten Disord 2009c;12:449-459.
4. Aron A, Dowson J, Sahakian B, Robbins T: Methylphenidate improves response inhibition in adults with attention-deficit/hyperactivity disorder. Biol Psychiatry 2003;54:1465-1468. (Pubitemid 37522172)
5. Barkley RA, Murphy KR, Fischer M: ADHD in Adults: What the Science Says. New York, Guilford Press, 2008.
6. Barton J: Atomoxetine: A new pharmacotherapeutic approach in the management of attention deficit/ hyperactivity disorder. Arch Dis Child 2005;90 (suppl 1):26-29.
7. Biederman J, Mick E, Surman C, Doyle R, Hammerness P, et al.: A randomized placebo-controlled trial of OROS methylphenidate in adults with attentiondeficit/ hyperactivity disorder. Biol Psychiatry 2006; 59:829-835.
8. Bouffard R, Hechtman L, Minde K, Iaboni-Kassab F: The efficacy of 2 different dosages of methylphenidate in treating adults with attention-deficit hyperactivity disorder. Can J Psychiatry 2003;48:546-554. (Pubitemid 37280044)
9. Bramham J, Young S, Bickerdike A, Spain D, McCartan D, Xenitidis K: Evaluation of group cognitive behavioral therapy for adults with ADHD. J Atten Disord 2009;12:433-441.
10. British Medical Association und The Royal Pharmaceutical Society of Great Britain: British National Formulary (BNF) 54. London, British Medical Association und Royal Pharmaceutical Society of Great Britain, 2007.
11. Carpentier P, de Jong C, Dijkstra B, Verbrugge C, Krabbe P: A controlled trial of methylphenidate in adults with attention deficit/hyperactivity disorder and substance use disorders. Addiction 2005;100: 1868-1874. (Pubitemid 41775212)
12. Castells X, Ramos-Quiroga JA, Rigau D, Bosch R, Nogueira M, Vidal X, Casas M: Efficacy of methylphenidate for adults with attention-deficit hyperactivity disorder: A meta-regression analysis. CNS Drugs 2011;25:157-169.
13. Conners C, Levin E, Sparrow E, Hinton S, Erhardt D, et al.: Nicotine and attention in adult attention deficit hyperactivity disorder (ADHD). Psychopharmacol Bull 1996;32:67-73. (Pubitemid 26176204)
14. Dilling H, Mombour W, Schmidt MH: Internationale Klassifikation psychischer Störungen. ICD-10 Kapitel V (F). Diagnostische Kriterien für Forschung und Praxis, ed 3. Bern, Huber, 2004.
15. Ebert D, Krause J, Roth-Sackenheim C: ADHS im Erwachsenenalter: Leitlinien auf der Basis eines Expertenkonsensus mit Unterstützung der DGPPN. Nervenarzt 2003;74:939-946.
16. Fabiano GA, Pelham WE, Coles EK, Gnagy EM, Chronis-Tuscano A, O'Connor BC: A meta-analysis of behavioral treatments for attention-deficit/ hyperactivity disorder. Clin Psychol Rev 2009;29: 129-140.
17. Faraone SV, Glatt SJ: A comparison of the efficacy of medications for adult attention-deficit/hyperactivity disorder using meta-analysis of effect sizes. J Clin Psychiatry 2010;71:754-763.
18. Faraone SV, Spencer T, Aleardi M, Pagano C, Biederman J: Meta-analysis of the efficacy of methylphenidate for treating adult attention-deficit/ hyperactivity disorder. J Clin Psychopharmacol 2004;24:24-29. (Pubitemid 38134162)
19. Fayyad J, De Graaf R, Kessler R, Alonso J, Angermeyer M, et al.: Cross-national prevalence and correlates of adult attention-deficit hyperactivity disorder. Br J Psychiatry 2007;190:402-409. (Pubitemid 46706952)
20. Halperin JM, Schulz KP: Revisiting the role of the prefrontal cortex in the pathophysiology of attention-deficit/hyperactivity disorder. Psychol Bull 2006;132:560-581. (Pubitemid 44212071)
21. Hesslinger B, van Elst LT, Nyberg E, Dykierek P, Richter H, et al.: Psychotherapy of attention deficit hyperactivity disorder in adults: A pilot study using a structured skills training program. Eur Arch Psychiatry Clin Neurosci 2002;252:177-184. (Pubitemid 36056674)
22. Jain U, Hechtman L, Weiss M, Ahmed TS, Reiz JL, et al.: Efficacy of a novel biphasic controlled-release methylphenidate formula in adults with attentiondeficit/ hyperactivity disorder: Results of a doubleblind placebo-controlled crossover study. J Clin Psychiatry 2007;68:268-277. (Pubitemid 46362649)
23. Kinsbourne M, De Quiros G, Rufo D: Adult ADHD-controlled medication assessment. Adult Atten Defic Disord 2001;931:287-296.
24. Koesters M, Becker T, Kilian R, Fegert JM, Weinmann S: Limits of metaanalysis: Methylphenidate in the treatment of adult attention-deficit hyperactivity disorder. J Psychopharmacol 2009;23:733-744.
25. Kooij J, Burger H, Boonstra A, Van der Linden P, Kalma L, Buitelaar J: Efficacy and safety of methylphenidate in 45 adults with attention-deficit/ hyperactivity disorder: A randomized placebo-controlled double-blind cross-over trial. Psychol Med 2004;34: 973-982. (Pubitemid 39199967)
26. Kuperman S, Perry PJ, Gaffney GR, Lund BC, Bever-Stille KA, et al.: Bupropion SR vs. methylphenidate vs. placebo for attention deficit hyperactivity disorder in adults. Ann Clin Psychiatry 2001;13:129-134. (Pubitemid 34020146)
27. Laucht M, Skowronek MH, Becker K, Schmidt MH, Esser G, Schulze TG, Rietschel M: Interacting effects of the dopamin transporter gene and psychosocial diversity on attention-deficit/hyperactivity disorder symptoms among 15-years-olds from a high-risk community sample. Arch Gen Psychiatry 2007;64:585-590. (Pubitemid 46718291)
28. Lauth G, Raven H: Aufmerksamkeitsdefizit/ Hyperaktivitätsstörungen (ADHS) im Erwachsenenalter: Ein Review. Psychotherapeutenjournal 2009;1:17-30.
29. Lauth GW, Breuer J, Minsel WR: Goal Attainment Scaling in der Ermittlung der Behandlungswirksamkeit bei der behavioralen Therapie von Erwachsenen mit ADHS: Eine Pilotstudie. Z Psychiatr Psychol Psychother 2010;58:45-53.
30. Lauth GW, Minsel W: ADHS bei Erwachsenen: Diagnostik und Behandlung von Aufmerksamkeits-/ Hyperaktivitätsstörungen. Göttingen, Hogrefe, 2009.
31. Levin E, Conners C, Silva D, Canu W, March J: Effects of chronic nicotine and methylphenidate in adults with attention deficit/hyperactivity disorder. Exp Clin Psychopharmacol 2001;9:83-90. (Pubitemid 32852217)
32. Levin E, Conners C, Sparrow E, Hinton S, Erhardt D, et al.: Nicotine effects on adults with attention-deficit hyperactivity disorder. Psychopharmacology 1996;123:55-63.
33. Linehan MM: Cognitive Behavioral Treatment of Borderline Personality Disorder. New York, Guilford Press, 1993.
34. Mattes J, Boswell L, Oliver H: Methylphenidate effects on symptoms of attention deficit disorder in adults. Arch Gen Psychiatry 1984;41:1059-1063.
35. McGough JJ, Barkley RA: Diagnostic controversies in adult attention deficit hyperactivity disorder. Am J Psychiatry 2004;161:1948-1956. (Pubitemid 39441393)
36. Medori R, Ramos-Quiroga J, Casas M, Kooij J, Niemela A, et al.: A randomized placebo-controlled trial of three fixed dosages of prolonged-release OROS methylphenidate in adults with attentiondeficit/ hyperactivity disorder. Biol Psychiatry 2008; 63:981-989.
37. Meszaros A, Czobor P, Balint S, Komlosi S, Simon V, Bitter I: Pharmacotherapie of adult attention deficit hyperactivity disorder (ADHD): A meta-analysis. Int J Neuropsychopharmacol 2009;12:1137-1147.
38. Michelson D, Adler L, Spencer T, Reimherr F, West S, et al.: Atomoxetine in adults with ADHD: Two randomized placebo-controlled studies. Biol Psychiatry 2003;53:112-120. (Pubitemid 36126473)
39. Miller TW, Nigg JT, Faraone SV: Axis I and II comorbidity in adults with ADHD. J Abnorm Psychol 2007;116:519-528. (Pubitemid 47444688)
40. Monastra VJ, Lubar FJ, Linden M: The development of a quantitative electroencephalographic scanning process for attention deficit-hyperactivity disorder: Reliability and validity studies. Neuropsychology 2001;15:136-144. (Pubitemid 32126003)
41. National Collaborating Centre for Mental Health: Diagnosis and Management of ADHD in Children, Young People and Adults. London, The British Psychological Society and The Royal College of Psychiatrists, 2009.
42. Paterson R, Douglas C, Hallmayer J, Hagan M, Krupenia Z: A randomised double-blind placebocontrolled trial of dexamphetamine in adults with attention deficit hyperactivity disorder. Aust N Z J Psychiatry 1999;33:494-502. (Pubitemid 29386870)
43. Philipsen A, Richter H, Peters J, Alm B, Sobanski E, et al.: Structured group psychotherapy in adults with attention deficit hyperactivity disorder. J Nerv Ment Dis 2007;195:1013-1019. (Pubitemid 350306555)
44. Philipsen A, van Elst LT, Lesch KP, Jans T, Warnke A: Wirksamkeit und Wirkmechanismen von Psychotherapie bei der Behandlung der Aufmerksamkeitsdefizit-/ Hyperaktivitätsstörung (ADHS) bei Kindern und Erwachsenen. Psychother Psych Med 2009;59:132-140.
45. Prosser B, Reid R: Psychostimulant use for children with ADHD in Australia. J Emot Behav Disord 1999;7:110-117.
46. Reimherr F, Williams E, Strong R, Mestas R, Soni P, Marchant B: Double-blind placebo-controlled crossover study of osmotic release oral system methylphenidate in adults with ADHD with assessment of oppositional and emotional dimensions of the disorder. J Clin Psychiatry 2007;68:93-101. (Pubitemid 46220130)
47. Reimherr FW, Hedges DW, Strong RE, Marchant BK, Williams ED: Bupropion SR in adults with ADHD: A short-term placebo-controlled trial. Neuropsychiatr Dis Treat 2005;1:245-251.
48. Retz-Junginger P, Retz W, Blocher D, Weijers HG, Trott GE, Wender PH, Rössler M: Wender-Utah Rating Scale (WURS-K). Nervenarzt 2002; 73:830-839.
49. Rösler M, Fischer R, Ammer R, Ose C, Retz W: A randomised placebo-controlled 24-week study of low-dose extended-release methylphenidate in adults with attention-deficit/hyperactivity disorder. Eur Arch Psychiatry Clin Neurosci 2009;259:120-129; Erratum 2009;259:368.
50. Rostain AL, Ramsay JR: A combined treatment approach for adults with ADHD-results of an open study of 43 patients. J Atten Disord 2006;10:150-159. (Pubitemid 44622769)
51. Rustenbach SJ: Metaanalyse: Eine anwendungsorientierte Einführung. Bern, Hans Huber, 2003.
52. Safren SA, Otto MW, Sprich S, Winett CL, Wilens TE, Biederman J: Cognitive-behavioral therapy for ADHD in medication-treated adults with continued symptoms. Behav Res Ther 2005;43:831-842. (Pubitemid 40719607)
53. Sanchez-Mora C, Ribases M, Ramos-Quiroga JA, Casas M, Bosch R, et al.: Meta-analysis of brainderived neurotrophic factor p.Val66Met in adult ADHD in four European populations. Am J Med Genet B Neuropsychiatr Genet 2010;153:512-523.
54. Saß H, Wittchen HU, Zaudig M, Houben I: Diagnostisches und statistisches Manual psychischer Störungen-Textrevision-DSM-IV-TR. Göttingen, Hogrefe, 2003.
55. Schmidt S, Petermann F: Developmental psychopathology: Attention deficit hyperactivity disorder (ADHD). BMC Psychiatry 2009;9:Art. 58.
56. Schubiner H, Saules K, Arfken C, Johanson C, Schuster C, et al.: Double-blind placebo-controlled trial of methylphenidate in the treatment of adult ADHD patients with comorbid cocaine dependence. Exp Clin Psychopharmacol 2002;10:286-294. (Pubitemid 34919937)
57. Simpson D, Plosker GL: Atomoxetine: A review of its use in adults with attention deficit hyperactivity disorder. Drugs 2004;64:205-222. (Pubitemid 38186965)
58. Sobanski E, Alm B: Aufmerksamkeitsdefizi-/ Hyperaktivitätsstörung (ADHS) bei Erwachsenen: Ein Überblick. Nervenarzt 2004;75:697-716.
59. Solanto MV, Marks DJ, Mitchell KJ, Wasserstein J, Kofman MD: Development of a new psychosocial treatment for adult ADHD. J Attent Disord 2008; 11:728-736.
60. Spencer T, Biederman J, Wilens T, Doyle R, Surman C, et al.: A large double-blind randomized clinical trial of methylphenidate in the treatment of adults with attention-deficit/hyperactivity disorder. Biol Psychiatry 2005;57:456-463. (Pubitemid 40311979)
61. Spencer T, Biederman J, Wilens T, Faraone S, Prince J, et al.: Efficacy of a mixed amphetamine salts compound in adults with attention-deficit/ hyperactivity disorder. Arch Gen Psychiatry 2001;58:775-782. (Pubitemid 32717803)
62. Spencer T, Biederman J, Wilens T, Prince J, Hatch M, et al.: Effectiveness and tolerability of tomoxetine in adults with attention deficit hyperactivity disorder. Am J Psychiatry 1998;155:693-695. (Pubitemid 28225414)
63. Spencer T, Wilens T, Biederman J, Faraone S, Ablon J, Lapey K: A double-blind crossover comparison of methylphenidate and placebo in adults with childhood-onset attention-deficit hyperactivity disorder. Arch Gen Psychiatry 1995;52:434-443.
64. Spencer TJ, Adler LA, McGough JJ, Muniz R, Jiang H, et al.: Efficacy and safety of dexmethylphenidate extended-release capsules in adults with attentiondeficit/ hyperactivity disorder. Biol Psychiatry 2007; 61:1380-1387. (Pubitemid 46855767)
65. Spencer TJ, Adler LA, Weisler RH, Youcha SH: Triple-bead mixed amphetamine salts (SPD465), a novel enhanced extended-release amphetamine formulation for the treatment of adults with ADHD: A randomized double-blind multicenter placebo-controlled study. J Clin Psychiatry 2008;69: 1437-1448.
66. Stevenson CS, Whitmont S, Bornholt L, Livesey D, Stevenson RJ: A cognitive remediation programme for adults with attention deficit hyperactivity disorder. Aust N Z J Psychiatry 2002;36:610-616. (Pubitemid 35174399)
67. Taylor F, Russo J: Comparing guanfacine and dextroamphetamine for the treatment of adult attention-deficit/hyperactivity disorder. J Clin Psychopharmacol 2001;21:223-228. (Pubitemid 32221061)
68. Taylor F, Russo J: Efficacy of modafinil compared to dextroamphetamine for the treatment of attention deficit hyperactivity disorder in adults. J Child Adolesc Psychopharmacol 2000;10:311-320. (Pubitemid 32103907)
69. Taylor F, Russo J: Comparing guanfacine and dextroamphetamine for the treatment of adult attention-deficit/hyperactivity disorder. J Clin Psychopharmacol 2001;21:223-228. (Pubitemid 32221061)
70. Tenenbaum S, Paull JC, Sparrow EP, Dodd DK, Green L: An experimental comparison of Pycnogenol and methylphenidate in adults with attention-deficit/ hyperactivity disorder (ADHD). J Atten Disord 2002;6:49-60.
71. Turner D, Clark L, Dowson J, Robbins T, Sahakian B: Modafinil improves cognition and response inhibition in adult attention-deficit/hyperactivity disorder. Biol Psychiatry 2004;55:1031-1040. (Pubitemid 38581919)
72. Verster J, Bekker E, de Roos M, Minova A, Eijken E, et al.: Methylphenidate significantly improves driving performance of adults with attention-deficit hyperactivity disorder: A randomized crossover trial. J Psychopharmacol 2008;22:230-237. (Pubitemid 351847448)
73. Virta M, Vedenpää A, Grönroos N, Chydenius E, Partinen M, et al.: Adults with ADHD benefit from cognitive-behaviorally oriented group rehabilitation. J Atten Disord 2008;12:218-226.
74. Volkow ND, Wang GJ, Fowler JS, et al.: Evidence that methylphenidate enhances the saliency of a mathematical task by increasing dopamine in the human brain. Am J Psychiatry 2004;161:1173-1180. (Pubitemid 38859165)
75. Vorstand der Bundesärztekammer: Stellungnahme zur Aufmerksamkeitsdefizit-/Hyperaktivitätsstörung. http://www. bundesaerztekammer.de/page.asp? his=0.7.47.3161.3163.2005. Netzzugriff am 28.01.2009.
76. Weisler RH, Biederman J, Spencer TJ, Wilens TE, Faraone SV, et al.: Mixed amphetamine salts extended-release in the treatment of adult ADHD: A randomized controlled trial. CNS Spectr 2006;11: 625-639. (Pubitemid 44253518)
77. Weiss M, Hechtman L: A randomized double-blind trial of paroxetine and/or dextroamphetamine and problem-focused therapy for attention-deficit/ hyperactivity disorder in adults. J Clin Psychiatry 2006;67:611-619. (Pubitemid 43764238)
78. Wender P, Reimherr F, Wood D: Attention deficit disorder (minimal brain-dysfunction) in adults. Arch Gen Psychiatry 1981;38:449-456.
79. Wender P, Reimherr F, Wood D, Ward M: A controlled-study of methylphenidate in the treatment of attention deficit disorder residual type in adults. Am J Psychiatry 1985;142:547-552. (Pubitemid 15034621)
80. Wiggins D, Singh K, Getz HD, Hutchins DE: Effects of brief group intervention for adults with attention deficit/hyperactivity disorder. J Ment Health Couns 1999;21:82-93.
81. Wilens T, Biederman J, Prince J, Spencer T, Faraone S, et al.: Six-week double-blind placebo-controlled study of desipramine for adult attention deficit hyperactivity disorder. Am J Psychiatry 1996;153: 1147-1153. (Pubitemid 26299833)
82. Wilens T, Haight B, Horrigan J, Hudziak J, Rosenthal N, et al.: Bupropion XL in adults with attentiondeficit/ hyperactivity disorder: A randomized placebo-controlled study. Biol Psychiatry 2005;57:793-801. (Pubitemid 40487924)
83. Wilens T, Spencer T, Biederman J, Girard K, Doyle R, et al.: A controlled clinical trial of bupropion for attention deficit hyperactivity disorder in adults. Am J Psychiatry 2001;158:282-288. (Pubitemid 32116526)
84. Wilens TE, Klint T, Adler L, West S, Wesnes K, et al.: A randomized controlled trial of a novel mixed monoamine reuptake inhibitor in adults with ADHD. Behav Brain Funct 2008;4:24.
85. Wilens TE, McDermott SP, Biederman J, Abrantes A, Hahesy A, Spencer TJ: Cognitive therapy in the treatment of adults with ADHD: A systematic chart review of 26 cases. J Cognit Psychother 1999;13: 215-227.
86. Wolraich ML, McGuinn L, Doffing M: Treatment of attention deficit hyperactivity disorder in children and adolescents: Safety considerations. Drug Safety 2007;30:17-26. (Pubitemid 46072355)
87. Wood D, Reimherr F, Wender P, Johnson G: Diagnosis and treatment of minimal brain dysfunction in adults-preliminary report. Arch Gen Psychiatry 1976;33:1453-1460. (Pubitemid 8005003)
88. Zylowska L, Ackermann DL, Yang MH, Futrell JL, Horton NL, et al.: Mindfulness meditation training in adults and adolescents with ADHD. J Atten Disord 2008;11:737-746.